Pindong Li

804 total citations
29 papers, 614 citations indexed

About

Pindong Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pindong Li has authored 29 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Pindong Li's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Pindong Li is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers) and Gastric Cancer Management and Outcomes (3 papers). Pindong Li collaborates with scholars based in China and United States. Pindong Li's co-authors include Zhenwei Zou, Yong Li, Charlie Ma, Wenjie Zhang, Rubo Cao, Jianli Hu, Fengjun Cao, Xin Peng, Peng Chen and Bi‐Cheng Wang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and ACS Applied Materials & Interfaces.

In The Last Decade

Pindong Li

27 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pindong Li China 15 340 169 130 89 77 29 614
Wencai Guan China 16 356 1.0× 226 1.3× 118 0.9× 81 0.9× 76 1.0× 41 658
Jiazhang Wei China 14 324 1.0× 194 1.1× 126 1.0× 94 1.1× 75 1.0× 46 606
Bikash Chandra Jena India 13 451 1.3× 236 1.4× 144 1.1× 75 0.8× 46 0.6× 24 667
Rongjian Su China 16 410 1.2× 101 0.6× 125 1.0× 50 0.6× 47 0.6× 27 654
Ningjing Lei China 16 453 1.3× 272 1.6× 111 0.9× 111 1.2× 78 1.0× 38 691
Rong Du China 14 249 0.7× 163 1.0× 153 1.2× 129 1.4× 47 0.6× 33 550
Haidong Gao China 17 643 1.9× 246 1.5× 210 1.6× 90 1.0× 80 1.0× 46 923
Fang Sui China 14 394 1.2× 142 0.8× 137 1.1× 68 0.8× 56 0.7× 33 663
Mohammad‐Javad Sanaei Iran 15 276 0.8× 102 0.6× 181 1.4× 205 2.3× 80 1.0× 29 607

Countries citing papers authored by Pindong Li

Since Specialization
Citations

This map shows the geographic impact of Pindong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pindong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pindong Li more than expected).

Fields of papers citing papers by Pindong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pindong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pindong Li. The network helps show where Pindong Li may publish in the future.

Co-authorship network of co-authors of Pindong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Pindong Li. A scholar is included among the top collaborators of Pindong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pindong Li. Pindong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Min, Shengli Yang, Lei Zhao, et al.. (2025). Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study. Journal for ImmunoTherapy of Cancer. 13(1). e009415–e009415. 4 indexed citations
2.
3.
4.
Huang, Yan, et al.. (2024). Factors associated with HPV vaccine hesitancy among college students: A cross-sectional survey based on 3Cs and structural equation model in China. Human Vaccines & Immunotherapeutics. 20(1). 2309731–2309731. 13 indexed citations
5.
Zhang, Sisi, Yue Hu, Xiaoshu Zhou, et al.. (2022). Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc. International Journal of Radiation Oncology*Biology*Physics. 115(5). 1244–1256. 20 indexed citations
6.
Li, Yong, Yingqiu Song, Pindong Li, et al.. (2020). Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma. Journal for ImmunoTherapy of Cancer. 8(1). e000111–e000111. 26 indexed citations
7.
Wen, Lu, Shengli Yang, Pindong Li, et al.. (2020). iASPP-Mediated ROS Inhibition Drives 5-Fu Resistance Dependent on Nrf2 Antioxidative Signaling Pathway in Gastric Adenocarcinoma. Digestive Diseases and Sciences. 65(10). 2873–2883. 9 indexed citations
8.
Mi, Chen, Fan Li, Simin Zhang, et al.. (2019). LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression. Cell Death and Disease. 10(2). 70–70. 27 indexed citations
9.
Zhou, Mengting, Jun Fan, Zhenyu Li, et al.. (2019). Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer. Respiratory Research. 20(1). 248–248. 18 indexed citations
10.
Wang, Bi‐Cheng, Rubo Cao, Pindong Li, & Chen Fu. (2019). The effects and safety of PD‐1/PD‐L1 inhibitors on head and neck cancer: A systematic review and meta‐analysis. Cancer Medicine. 8(13). 5969–5978. 24 indexed citations
11.
Cao, Fengjun, Mingxing Li, Pindong Li, et al.. (2018). Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer. Redox Biology. 20. 451–457. 19 indexed citations
12.
Zou, Zhenwei, Ting Liu, Yong Li, et al.. (2018). Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS. Redox Biology. 16. 226–236. 49 indexed citations
13.
Li, Yong, Fengjun Cao, Mingxing Li, et al.. (2018). Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. Journal of Experimental & Clinical Cancer Research. 37(1). 259–259. 82 indexed citations
14.
Liu, Zhao, Chen Mi, Linka Xie, et al.. (2018). CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling. Aging. 10(10). 2570–2584. 29 indexed citations
15.
16.
Liu, Ting, Xuefeng Kan, Charlie Ma, et al.. (2017). GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma. Tumor Biology. 39(6). 3726131641–3726131641. 32 indexed citations
17.
18.
Peng, Gang, Rubo Cao, Jun Xue, et al.. (2014). Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma. Radiology and Oncology. 48(1). 40–49. 8 indexed citations
19.
Cao, Rubo, Qian Ding, Pindong Li, et al.. (2013). SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer. Radiation Oncology. 8(1). 178–178. 19 indexed citations
20.
Zou, Zhenwei, Ting Liu, Jingfeng Li, et al.. (2013). Biocompatibility of functionalized designer self‐assembling nanofiber scaffolds containing FRM motif for neural stem cells. Journal of Biomedical Materials Research Part A. 102(5). 1286–1293. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wencai Guan Breakdown of academic impact, for papers by Jiazhang Wei Breakdown of academic impact, for papers by Bikash Chandra Jena Breakdown of academic impact, for papers by Rongjian Su Breakdown of academic impact, for papers by Ningjing Lei Breakdown of academic impact, for papers by Rong Du Breakdown of academic impact, for papers by Haidong Gao Breakdown of academic impact, for papers by Fang Sui Breakdown of academic impact, for papers by Mohammad‐Javad Sanaei
Rankless by CCL
2026